CAZZANIGA MARINA ELENA

Turner, N., Saura, C., Aftimos, P., Van Den Tweel, E., Oesterholt, M., Koper, N., et al. (2025). Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP). JOURNAL OF CLINICAL ONCOLOGY, 43(5), 513-523 [10.1200/JCO.24.00529]. Dettaglio

Malighetti, F., Villa, M., Villa, A., Pelucchi, S., Aroldi, A., Cortinovis, D., et al. (2025). Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(5) [10.3390/ijms26051943]. Dettaglio

Cazzaniga, M., Pepe, F., Rossi, E., Coltelli, L., Beano, A., Valerio, M., et al. (2025). A Phase 2, Open Label, Multicenter, Single Arm Trial Evaluating the Activity and Safety of Abemaciclib + Aromatase Inhibitors (AIs) as Second-Line Treatment After First-Line Fulvestrant in Hormone-Receptor-Positive (HR+), Human-Epidermal-Growth-Factor-Receptor-Negative (HER2-) Metastatic Breast Cancer (MBC) Patients. Final Results of HERMIONE-7 Trial. CLINICAL BREAST CANCER, 25(6), 560-565 [10.1016/j.clbc.2025.05.003]. Dettaglio

Ardakani, K., Pepe, F., Capici, S., Clementi, T., Cazzaniga, M. (2025). Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC). CURRENT ONCOLOGY, 32(7) [10.3390/curroncol32070387]. Dettaglio

Cazzaniga, M., Huober, J., Tamma, A., Emde, A., Thoele, K., O'Shaughnessy, J. (2025). Oral Anticancer Therapies: Addressing Nonadherence in Patients With Breast Cancer. CLINICAL BREAST CANCER, 25(4), 307-324 [10.1016/j.clbc.2024.12.011]. Dettaglio